You have 9 free searches left this month | for more free features.

anti-TNF-alpha

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Rheumatoid Arthritis Trial in Beijing (GB242, Infliximab)

Unknown status
  • Rheumatoid Arthritis
  • GB242
  • Infliximab
  • Beijing, Beijing, China
    Peking University People Hospital
Nov 25, 2019

Arthritis, Psoriatic Trial in Worldwide (Guselkumab 100 mg, Placebo)

Completed
  • Arthritis, Psoriatic
  • Guselkumab 100 mg
  • Placebo
  • Brussels, Belgium
  • +116 more
Nov 29, 2021

Axial Spondyloarthritis Trial in Besançon (Blood sample, anti-TNF antibody administration, anti-IL-17 antibody administration)

Recruiting
  • Axial Spondyloarthritis
  • Blood sample
  • +2 more
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
May 31, 2022

Type 1 Diabetes Trial in La Jolla, Seattle (Etanercept, Vedolizumab)

Recruiting
  • Type 1 Diabetes
  • La Jolla, California
  • +1 more
Jul 21, 2022

HIV Trial in Honolulu, New York, Cleveland (Tumor Necrosis Factor soluble receptor-immunoadhesin complex)

Completed
  • HIV Infections
  • Tumor Necrosis Factor soluble receptor-immunoadhesin complex
  • Honolulu, Hawaii
  • +2 more
Oct 28, 2021

Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes

Recruiting
  • Toxicity, Drug
  • +2 more
  • Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
  • Leiden, Netherlands
    Leiden University Medical Center
Aug 16, 2022

Crohn Disease Trial in Paris (Fecal Microbiota Transplantation (FMT), Sham-transplantation ())

Recruiting
  • Crohn Disease
  • Fecal Microbiota Transplantation (FMT)
  • Sham-transplantation (placebo)
  • Paris, France
    Gastroenterology Department of Saint Antoine Hospital
Jun 20, 2022

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Biologics or Small Molecule Therapies in Inflammatory Bowel

Completed
  • Crohn's Disease
  • Ulcerative Colitis
    • New York, New York
    • +1 more
    Jan 9, 2023

    Combined Microbiota and Metabolic Signature in Ulcerative

    Not yet recruiting
    • Ulcerative Colitis
    • (no location specified)
    Jan 26, 2023

    Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

    Recruiting
    • Depressive Disorder, Major
    • +2 more
    • New Haven, Connecticut
      Yale University
    Aug 8, 2022

    Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)

    Completed
    • Rheumatoid Arthritis
    • ISIS 104838
    • Birmingham, Alabama
    • +30 more
    Dec 1, 2022

    Post-Operative Crohn's Disease Outcome in Children

    Recruiting
    • Crohn Disease
    • Petach Tikva, Israel
      Schneider Children's Hospital
    Sep 25, 2021

    Intrauterine Growth Restriction in Pre-eclamptic Women

    Not yet recruiting
    • alpha1 Anti-trypsin
    • +2 more
    • Alpha1 -Antitrypsin level
    • (no location specified)
    Nov 18, 2022

    Glioma of Brain Trial in Bern, Lausanne, Zürich (L19TNF)

    Active, not recruiting
    • Glioma of Brain
    • Bern, Switzerland
    • +2 more
    Apr 7, 2022

    COPD Exacerbation Blood and Urine Biomarkers Study

    Recruiting
    • Chronic Obstructive Pulmonary Disease
    • +2 more
      • New York, New York
        Columbia University Medical Center
      Oct 11, 2022

      Rheumatoid Arthritis Trial in Le Kremlin-Bicêtre (sms and emails reminders, No reminders)

      Completed
      • Rheumatoid Arthritis
      • sms and emails reminders
      • No reminders
      • Le Kremlin-Bicêtre, France
        Hôpital Bicêtre
      Oct 25, 2022

      Sexual Function in Patients With Crohn's Disease

      Completed
      • Crohn's Disease
      • IBD
      • Baltimore, Maryland
      • +3 more
      Feb 23, 2022

      Nerve Conduction Studies in Ankylosing Spondylitis

      Completed
      • Anti - TNF Therapy
      • +2 more
      • Anti-TNF agents
      • Conventional therapy users for the last 5 years
      • Istanbul, Turkey
        Istanbul Physical Medicine and Rehabilitation Training and resea
      Jun 21, 2021

      Long-term Outcome of TNF Alpha Therapy in IBD

      Completed
      • IBD
      • TNF Alpha therapy
      • Graz, Austria
        Medical University of Graz
      Feb 23, 2021

      Ustekinumab in Active Crohn's Disease

      Completed
      • Crohn Disease
      • Evaluation of biological predictive factors of clinical response to ustekinumab
      • Pierre-Bénite, France
        Centre hospitalier Lyon Sud
      Aug 23, 2022

      IBD, Crohn Disease, Ulcerative Colitis Trial in Hartford, Cincinnati, Columbus (2'-Fucosyllactose, Placebo)

      Recruiting
      • Inflammatory Bowel Diseases
      • +2 more
      • Hartford, Connecticut
      • +2 more
      Jan 31, 2022

      Rheumatoid Arthritis Trial in United States (Etanercept, Adalimumab)

      Completed
      • Rheumatoid Arthritis
      • Birmingham, Alabama
      • +6 more
      Aug 31, 2021

      Arthritis, Psoriatic Trial in Worldwide (Guselkumab, Placebo)

      Recruiting
      • Arthritis, Psoriatic
      • Mountain Brook, Alabama
      • +199 more
      Jan 17, 2023

      Predictors of Prognosis in IBD Patients

      Recruiting
      • Inflammatory Bowel Diseases
      • +2 more
      • Endoscopic biopsy
      • Seongnam-si, Gyeonggi-do, Korea, Republic of
        Seoul National University Bundang Hospital
      Dec 7, 2022